TY - CONF
T1 - An open-label phase IIa trial assessing the pharmacokinetics, safety and efficacy of dupilumab in a paediatric population with moderate-to-severe atopic dermatitis
JO - BRITISH JOURNAL OF DERMATOLOGY
PY - 2017/07/01
AU - Cork MJ
AU - Thaci D
AU - Davis JD
AU - Zhang Q
AU - Akinlade B
AU - Graham NMH
AU - Pirozzi G
AU - Bansal A
ED -
VL - 177
SP - 67
EP - 68
Y2 - 2025/01/07
ER -